Keratinocyte barrier homeostasis pathway

Keratinocyte barrier homeostasis pathways refer to the coordinated biological processes that establish and maintain the skin's physical and chemical permeability barrier. This system involves the terminal differentiation of keratinocytes into corneocytes, the assembly of the cornified envelope via transglutaminases, and the secretion of lipid lamellae containing ceramides, cholesterol, and free fatty acids (Proksch et al., 2008, J Clin Invest). These pathways are regulated by various signaling molecules, including the aryl hydrocarbon receptor (AhR), peroxisome proliferator-activated receptors (PPARs), and the vitamin D receptor (VDR) (Bikle, 2012, Nutrients). Defects in these pathways, such as mutations in the filaggrin (FLG) gene, are central to the pathogenesis of atopic dermatitis and other ichthyotic disorders, leading to increased transepidermal water loss and heightened sensitivity to environmental allergens (Palmer et al., 2006, Nat Genet). Pharmacological intervention aims to restore barrier integrity by inducing the expression of structural proteins or inhibiting inflammatory cytokines like IL-4 and IL-13 that suppress barrier-related genes (Guttman-Yassky et al., 2017, J Allergy Clin Immunol). Emerging therapies also target the microbiome-skin barrier axis to enhance the production of antimicrobial peptides and maintain a healthy skin pH. Overall, these pathways represent a critical interface between the internal environment and external stressors, making them a primary focus for dermatological drug development.

Other names

Epidermal barrier functionSkin barrier homeostasisKeratinocyte differentiation program

Restoration of barrier protein expression (e.g., filaggrin, loricrin) and lipid synthesis through modulation of signaling pathways such as AhR, PPAR, or JAK/STAT (Smith et al., 2017, J Am Acad Dermatol).